Tweet
Translation Google
Guangdong at the peak period of influenza cancel doctor prescribed Tamiflu prescription restrictions
Published: May 14, 2013 09:03 |Source: Nanfang Daily |
Nanfang Daily News (Reporter Chen Feng, Guangdong Wilson) Guangdong is peak season for influenza, Tamiflu is no longer a rescue medication, but the conventional anti-flu drugs, the province's hospitals at all levels to cancel the doctor prescribed the drug prescription restrictions. I learned yesterday, to further strengthen the province's human infection of H7N9 avian influenza medical treatment, to reduce severe cases, the Guangdong Provincial Health Department recently released "Guangdong Provincial medical institutions neuraminidase inhibitors clinical medicine guidelines (Trial)".
Early efficacy, as far as possible within 48 hours of onset
The so-called "neuraminidase inhibitors, including oseltamivir Wei, bar drugs such as zanamivir or peramivir, oseltamivir is well known to the public of the anti-influenza drug Tamiflu. The guidelines point out that the latest experimental studies have shown that neuraminidase inhibitors to treat different types of influenza (including human infection with the H7N9 avian influenza) early efficacy, should be started within 48 hours of the onset of use.
Provincial Health Department pointed out that the health administrative departments at all levels and at all levels of medical institutions is necessary to change the neuraminidase inhibitors understood as simply a misconception of the national emergency stockpile drugs, neuraminidase inhibitors should be clear is the treatment of different types of influenza conventional medicines, conventional anti-flu drugs, in the case of national controls or restrictions on the use of drugs, should return to a normal property of the anti-influenza drugs. The same time, we should fully recognize the timely given the various types of influenza neuraminidase inhibitor therapy can delay the development of severe cases, patients with drug indications should be timely treatment of neuraminidase inhibitors , no need to wait for the test results.
Guangdong is the peak period of influenza hospitals to purchase sufficient quantities of Tamiflu
Health Department requirements, various medical institutions at all levels can purchase a sufficient amount of neuraminidase inhibitors, reported to the local rectify unhealthy tendencies in the purchase and sale of pharmaceutical and medical services Leading Group Office of the record (subordinates, provincial government to various medical institutions the provincial pharmaceutical procurement center for the record). At present, the province positive influenza peak incidence (the dominant strain of H1N1 influenza virus), influenza deaths in patients with various medical institutions want to buy a sufficient amount of neuraminidase inhibitors for clinical normal anti-influenza treatment be used.
Various medical institutions at all levels want to cancel a doctor neuraminidase inhibitor prescription limit, the prescribing physician may need to be issued according to the disease neuraminidase inhibitors prescription, hospital administrative leadership or senior doctors do not need to sign an agreement.Good communication with patients and (or) family explanation before using neuraminidase inhibitors.
Severe hospitalized cases, it is recommended that Tamiflu oral treatment
The guidelines point out that the suspected or confirmed human cases of H7N9 avian influenza infection in the respiratory tract specimens using neuraminidase inhibitors should be sacrificing, and dynamic follow-up specimens were taken. Pay attention to the virus laboratory tests and antiviral treatment simultaneously. Do not have to wait for the laboratory-confirmed start antiviral therapy, in order to avoid delay in treatment time.
Given the current lack of inhalation tie zanamivir treatment of patients with severe influenza data, therefore, critically ill hospitalized patients and patients with complex disease, it is recommended to give oral oseltamivir (but not zanamivir) Inhalation tie treatment. Mild cases should be preferred oseltamivir or zanamivir. The oseltamivir dose for adults is 75mg, 2 times a day, 5-7 days of treatment. Severe cases, the dose may be doubled, treatment may be extended to 10 days. Pediatric patients should be administered according to the weight.
Author: Chen Feng, Guangdong Wilson
http://jiankang.cntv.cn/2013/05/14/ARTI1368493325332529.shtml
Guangdong at the peak period of influenza cancel doctor prescribed Tamiflu prescription restrictions
Published: May 14, 2013 09:03 |Source: Nanfang Daily |
Nanfang Daily News (Reporter Chen Feng, Guangdong Wilson) Guangdong is peak season for influenza, Tamiflu is no longer a rescue medication, but the conventional anti-flu drugs, the province's hospitals at all levels to cancel the doctor prescribed the drug prescription restrictions. I learned yesterday, to further strengthen the province's human infection of H7N9 avian influenza medical treatment, to reduce severe cases, the Guangdong Provincial Health Department recently released "Guangdong Provincial medical institutions neuraminidase inhibitors clinical medicine guidelines (Trial)".
Early efficacy, as far as possible within 48 hours of onset
The so-called "neuraminidase inhibitors, including oseltamivir Wei, bar drugs such as zanamivir or peramivir, oseltamivir is well known to the public of the anti-influenza drug Tamiflu. The guidelines point out that the latest experimental studies have shown that neuraminidase inhibitors to treat different types of influenza (including human infection with the H7N9 avian influenza) early efficacy, should be started within 48 hours of the onset of use.
Provincial Health Department pointed out that the health administrative departments at all levels and at all levels of medical institutions is necessary to change the neuraminidase inhibitors understood as simply a misconception of the national emergency stockpile drugs, neuraminidase inhibitors should be clear is the treatment of different types of influenza conventional medicines, conventional anti-flu drugs, in the case of national controls or restrictions on the use of drugs, should return to a normal property of the anti-influenza drugs. The same time, we should fully recognize the timely given the various types of influenza neuraminidase inhibitor therapy can delay the development of severe cases, patients with drug indications should be timely treatment of neuraminidase inhibitors , no need to wait for the test results.
Guangdong is the peak period of influenza hospitals to purchase sufficient quantities of Tamiflu
Health Department requirements, various medical institutions at all levels can purchase a sufficient amount of neuraminidase inhibitors, reported to the local rectify unhealthy tendencies in the purchase and sale of pharmaceutical and medical services Leading Group Office of the record (subordinates, provincial government to various medical institutions the provincial pharmaceutical procurement center for the record). At present, the province positive influenza peak incidence (the dominant strain of H1N1 influenza virus), influenza deaths in patients with various medical institutions want to buy a sufficient amount of neuraminidase inhibitors for clinical normal anti-influenza treatment be used.
Various medical institutions at all levels want to cancel a doctor neuraminidase inhibitor prescription limit, the prescribing physician may need to be issued according to the disease neuraminidase inhibitors prescription, hospital administrative leadership or senior doctors do not need to sign an agreement.Good communication with patients and (or) family explanation before using neuraminidase inhibitors.
Severe hospitalized cases, it is recommended that Tamiflu oral treatment
The guidelines point out that the suspected or confirmed human cases of H7N9 avian influenza infection in the respiratory tract specimens using neuraminidase inhibitors should be sacrificing, and dynamic follow-up specimens were taken. Pay attention to the virus laboratory tests and antiviral treatment simultaneously. Do not have to wait for the laboratory-confirmed start antiviral therapy, in order to avoid delay in treatment time.
Given the current lack of inhalation tie zanamivir treatment of patients with severe influenza data, therefore, critically ill hospitalized patients and patients with complex disease, it is recommended to give oral oseltamivir (but not zanamivir) Inhalation tie treatment. Mild cases should be preferred oseltamivir or zanamivir. The oseltamivir dose for adults is 75mg, 2 times a day, 5-7 days of treatment. Severe cases, the dose may be doubled, treatment may be extended to 10 days. Pediatric patients should be administered according to the weight.
Author: Chen Feng, Guangdong Wilson
http://jiankang.cntv.cn/2013/05/14/ARTI1368493325332529.shtml